Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: updates events MilitaryFriendly com
RTI Named One of the World’s Most Ethical Companies for the Fifth Year Share on: March 15, 2022 The recognition honors companies demonstrating exceptional leadership and a commitment to business integrity through best-in-class ethics, compliance, and …
RTI International Earns 2022 Military Friendly® Employer Designation Share on: November 11, 2021 The institute also earned a high ranking on the Military Friendly® Supplier Diversity Program list RTI International—a nonprofit research institute …
RTI named 2022 Best Place to Work for Disability Inclusion by Disability Equality Index® Share on: July 21, 2022 Top-scorers demonstrated commitment to disability inclusion and equality RTI International, a nonprofit research institute and parent company …
Understanding a Critical Element in the Search for Alzheimer’s Disease Treatments Share on: June 16, 2021 Image What Matters Most to Patients and Caregivers Dana DiBenedetti, PhD Executive Director, Patient-Centered Outcomes Assessment The devastating …
FDA and AMCP Guidance on Pre-Approval Submissions and the Continuous Process of Dossier Development Share on: December 20, 2019 Article contributed by: Shahnaz Khan, MPH , Executive Director, Market Access and Outcomes Strategy at RTI Health Solutions …
RTI Recognized by Newsweek as One of America’s Greatest Workplaces for Parents & Families Share on: November 20, 2023 The rankings acknowledge RTI as a family-friendly workplace in addition to a previous award as one of America’s Greatest Workplaces …
SIGMA Stakeholder Announcement Share on: January 15, 2021 Launch of the SIGMA Consortium heralds a new era of collaboration to better understand safety and effectiveness of medical interventions. Research institutions compete for resources to carry out …
… with different sets of benefits and potential adverse events. Treatment attributes are relative based on a person’s …
FORTEO® Post-Market Osteosarcoma Surveillance Program: Real-World Data Contributes to Label Change Share on: January 25, 2021 The US Food and Drug Administration (FDA) is no longer requiring a black box warning on the label for the drug FORTEO® …
6 Takeaways on the AMCP 4.1 Guidance in Action Share on: March 12, 2021 Insights from Working with Newest AMCP Format Guidance During 2020 In December of 2019, the Academy of Managed Care Pharmacy (AMCP) released Version 4.1 of the AMCP Format for …